• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Tuesday, December 3, 2019

    Time

    2:00 PM - 3:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      In November of 2017 HEPLISAV-B was approved for the prevention of hepatitis B. HePLISAV-B is a two-dose vaccine administered 4 weeks apart. It will be important for health care providers to be aware of these new options. Health care providers will need to understand how HEPLISAV-B compares to other commercially available hepatitis B vaccines. In addition, numerous limitations exist with the oral antiviral medications currently used to treat patients chronically infected with hepatitis B. New research is promising that we will have new oral antiviral therapies in the next 5 years. We will review the limitations with the current treatments and discuss agents that are currently in the pipeline.

      Handouts

      Slide Document 19007L01_6pp.pdf
      Slide Document 19007L01_2pp.pdf





      Financial Support By

      PharmCon, Inc
    • Pharmacist

      Recognize the epidemiology of hepatitis B
      Compare and contrast commercially available hepatitis B vaccines
      Identify limitations with current oral antiviral medications to treat hepatitis B

      Pharmacy Technician

      Recognize the epidemiology of hepatitis B
      Compare and contrast the schedules for commercially available hepatitis B vaccines
      List oral antiviral medications used to treat hepatitis B

      Nurse

      Recognize the epidemiology of hepatitis B
      Compare and contrast commercially available hepatitis B vaccines
      Identify limitations with current oral antiviral medications to treat hepatitis B
    • Repeat Presentation

      This presentation was last given on 12/3/2019 2:00 PM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-712670

      Universal Activity Number

      Pharmacist 0798-0000-19-077-L06-P

      Pharmacy Technician 0798-0000-19-077-L06-T

      Nurse 0798-0000-19-077-L06-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.